180 Life Sciences Stock Analysis

ATNF Stock  USD 1.16  0.02  1.69%   
180 Life Sciences is overvalued with Real Value of 0.92 and Target Price of 80.0. The main objective of 180 Life stock analysis is to determine its intrinsic value, which is an estimate of what 180 Life Sciences is worth, separate from its market price. There are two main types of 180 Life's stock analysis: fundamental analysis and technical analysis.
The 180 Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and 180 Life's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

180 Stock Analysis Notes

About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. 180 Life Sciences recorded a loss per share of 15.49. The entity had not issued any dividends in recent years. The firm had 1:19 split on the 28th of February 2024. 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on 180 Life Sciences please contact the company at 650 285 2387 or go to https://180lifesciences.com.

180 Life Sciences Investment Alerts

180 Life Sciences had very high historical volatility over the last 90 days
180 Life Sciences may become a speculative penny stock
180 Life Sciences currently holds 154.5 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (6.17 M) with profit before overhead, payroll, taxes, and interest of 0.
180 Life Sciences currently holds about 1.63 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Roughly 49.0% of 180 Life shares are held by company insiders
Latest headline from thelincolnianonline.com: Weiss Ratings Reaffirms Sell Rating for 180 Life Sciences

180 Life Sciences Upcoming and Recent Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

180 Largest EPS Surprises

Earnings surprises can significantly impact 180 Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-10
2022-09-300.2-1.4-1.6800 
2022-05-16
2022-03-31-2.61.03.6138 
2022-03-31
2021-12-31-2.61.03.6138 
View All Earnings Estimates

180 Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Virtu Financial Llc2024-12-31
0.0
Ifp Advisors, Llc2025-03-31
0.0
Anson Funds Management Lp2024-12-31
225.3 K
Hudson Bay Capital Management Lp2024-12-31
150 K
Ubs Group Ag2024-12-31
7.2 K
Tower Research Capital Llc2024-12-31
6.7 K
Blackrock Inc2025-03-31
564
Citigroup Inc2025-03-31
163
Sbi Securities Co Ltd2025-03-31
38.0
Bank Of America Corp2024-12-31
16.0
Northern Trust Investments N A2024-12-31
0.0
Note, although 180 Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

180 Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.72 M.

180 Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.20)(1.26)
Return On Capital Employed(0.68)(0.72)
Return On Assets(0.48)(0.51)
Return On Equity(0.67)(0.63)

Management Efficiency

180 Life Sciences has return on total asset (ROA) of (0.4387) % which means that it has lost $0.4387 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3521) %, meaning that it created substantial loss on money invested by shareholders. 180 Life's management efficiency ratios could be used to measure how well 180 Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.26. The current Return On Capital Employed is estimated to decrease to -0.72. At this time, 180 Life's Intangibles To Total Assets are most likely to increase slightly in the upcoming years.
Last ReportedProjected for Next Year
Book Value Per Share 10.11  9.60 
Tangible Book Value Per Share 1.78  1.69 
Enterprise Value Over EBITDA 0.44  0.46 
Price Book Value Ratio 0.18  0.19 
Enterprise Value Multiple 0.44  0.46 
Price Fair Value 0.18  0.19 
Enterprise Value-2.8 M-2.6 M
Leadership effectiveness at 180 Life Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta
0.179
Return On Assets
(0.44)
Return On Equity
(1.35)

Technical Drivers

As of the 19th of May, 180 Life owns the Standard Deviation of 8.22, market risk adjusted performance of 0.1108, and Coefficient Of Variation of 10047.31. 180 Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm 180 Life Sciences value at risk, expected short fall, as well as the relationship between the information ratio and downside deviation to decide if 180 Life Sciences is priced fairly, providing market reflects its prevailing price of 1.16 per share. Given that 180 Life Sciences is a hitting penny stock territory we recommend to closely look at its total risk alpha.

180 Life Sciences Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Exponential Moving Average is calculated by weighting recent values of 180 Life Sciences more heavily than older values.

180 Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 180 Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on 180 Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 180 Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

180 Life Outstanding Bonds

180 Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 180 Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 180 bonds can be classified according to their maturity, which is the date when 180 Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

180 Life Predictive Daily Indicators

180 Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 180 Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

180 Life Forecast Models

180 Life's time-series forecasting models are one of many 180 Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary 180 Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About 180 Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how 180 Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling 180 shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as 180 Life. By using and applying 180 Stock analysis, traders can create a robust methodology for identifying 180 entry and exit points for their positions.
Last ReportedProjected for Next Year

Current 180 Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. 180 analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. 180 analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
80.0Strong Buy1Odds
180 Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most 180 analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand 180 stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of 180 Life Sciences, talking to its executives and customers, or listening to 180 conference calls.
180 Analyst Advice Details

180 Stock Analysis Indicators

180 Life Sciences stock analysis indicators help investors evaluate how 180 Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading 180 Life shares will generate the highest return on investment. By understating and applying 180 Life stock analysis, traders can identify 180 Life position entry and exit signals to maximize returns.
Begin Period Cash FlowM
Long Term Debt6616.00
Common Stock Shares Outstanding915.4 K
Total Stockholder Equity9.3 M
Tax Provision-296 K
Cash And Short Term Investments4.6 M
Cash4.6 M
Accounts Payable1.9 M
Net Debt-4.4 M
50 Day M A1.0064
Total Current Liabilities3.5 M
Other Operating Expenses6.3 M
Non Current Assets Total7.6 M
Forward Price Earnings6.079
Stock Based Compensation308.2 K

Complementary Tools for 180 Stock analysis

When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing